Reaction to a Food and Drug Administration advisory panel’s recommendation on COVID-19 booster shots dominated the Sunday morning political talk shows.
The panel voted on Friday to recommend booster shots of Pfizer’s COVID-19 vaccine for people over the age of 65, as well as those who are at risk of severe disease — but only after voting against widespread boosters for everyone over the age of 16.
Read The Hill’s complete coverage below.
| NIH director expects booster shots to be expanded, despite FDA advisers’ recommendation |
| By JOSEPH CHOI |
| |
 |
| Francis Collins, director of the National Institutes of Health (NIH), said on Sunday that it would “surprise” him if COVID-19 booster shot aren’t expanded, despite a recommendation from a Food and Drug Administration (FDA) panel advising against widespread use.
“I think the big news is that they actually did approve the initiation of boosters and remember they’re taking a snapshot of right now. We’re going to see what happens in the coming weeks,” Collins said while appearing on “Fox News Sunday.” “It would surprise me if it does not become clear over the next few weeks, that administration of boosters may need to be enlarged.” |
| Read the full story here |
|
| |
 |
| |
|
|
| |
|
| |
| COVID-18 origins may never be known, Gottlieb says |
| By JOSEPH CHOI |
| |
| “Either we find the intermediate host — the animal that spread COVID — or there’s a whistleblower inside China. Or someone close to this, who knows that this came out of a lab, comes forward, defects, goes overseas, or we intercept some communication that we shouldn’t have had access to. Absent something like that, we’re not going to be able to answer this question,” former Food and Drug Administration (FDA) commissioner Scott Gottlieb said while appearing on CBS’s “Face the Nation.” |
| Read the full story here |
|
| |
|
| |
Copyright 2023 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
